Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Garfein

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The American Journal of Medicine|July 10, 2021
Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial FibrillationGeorge Cholack, Joshua Garfein, Rachel Krallman, et al.
International Journal of Molecular Sciences|October 14, 2022
Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and DementiaAkira Sekikawa, Whitney Wharton, Brittany Butts, et al.
International Journal of Medical Students|April 21, 2022
Predictors of Early (0-7 Days) and Late (8-30 Days) Readmission in a Cohort of Acute Coronary Syndrome PatientsGeorge Cholack, Joshua Garfein, Rachel Krallman, et al.
Hospital Practice (1995)|September 3, 2021
Early (0-7 day) and late (8-30 day) readmission predictors in acute coronary syndrome, atrial fibrillation, and congestive heart failure patientsGeorge Cholack, Joshua Garfein, Josh Errickson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The American Journal of Medicine|July 10, 2021
Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial FibrillationGeorge Cholack, Joshua Garfein, Rachel Krallman, et al.
International Journal of Molecular Sciences|October 14, 2022
Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and DementiaAkira Sekikawa, Whitney Wharton, Brittany Butts, et al.
International Journal of Medical Students|April 21, 2022
Predictors of Early (0-7 Days) and Late (8-30 Days) Readmission in a Cohort of Acute Coronary Syndrome PatientsGeorge Cholack, Joshua Garfein, Rachel Krallman, et al.
Hospital Practice (1995)|September 3, 2021
Early (0-7 day) and late (8-30 day) readmission predictors in acute coronary syndrome, atrial fibrillation, and congestive heart failure patientsGeorge Cholack, Joshua Garfein, Josh Errickson, et al.
Pageof 2